Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy--tolerance and addiction.
about
The shaman and the rave party: social pharmacology of ecstasy.Reduced cardiac contractile force due to sympathovagal dysfunction mediates the additive hypotensive effects of limited-access regimens of ethanol and clonidine in spontaneously hypertensive rats.The truth about pain management: the difference between a pain patient and an addicted patient.Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients.Pain and addiction: managing risk through comprehensive care.A successful palliative care intervention for cancer pain refractory to intrathecal analgesiaManagement of chronic pain with chronic opioid therapy in patients with substance use disordersMaking a case for programmable pumps over fixed rate pumps for the management of fluctuations in chronic pain and spasticity: a literature review.Acquired pharmaco-dynamic opioid tolerance: a concept analysis.Intrathecal morphine infusion for chronic non-malignant pain: a multiple center retrospective survey.Spinal morphine in nonmalignant chronic pain: a retrospective study in 39 patients.Outcome of intrathecal opioids in chronic non-cancer pain.Methadone in the intrathecal treatment of chronic nonmalignant pain resistant to other neuroaxial agents: the first experience.Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management.Alternative intrathecal agents for the treatment of pain.The Epidemic as Stigma: The Bioethics of Opioids
P2860
Q33184106-A1D9E8AE-ED49-48DD-B08E-FA7AE67E30D9Q34359993-F124CA6C-A782-4037-B81A-954477C8E1F6Q34499373-F36D6FCA-B8B8-4996-815E-D23E56F776F8Q35039614-09F5DFB5-CCB2-4366-BD01-DA6C75442D02Q35593793-85804280-1BBC-4496-8015-0658A4F788AFQ37310402-6E71C079-844C-44E4-B655-C1D1FAB4BE58Q37384173-785F5C78-82D3-45A0-8CC9-EE3FDDDC4ADCQ37523766-C24184EA-0FBB-444C-A2D0-82BFAA3E2335Q37965990-DE5C5BA8-6FAD-4ED0-B316-29E313FC45C4Q38100233-BFD9432D-CFD5-4EA7-9410-2FDC8050A777Q39375560-3FDC8A93-068E-4D23-9170-037DA2763FBDQ39405635-B2963ED6-BAD9-40AB-AE9F-080FD1379D86Q39412310-40C5C7FE-580B-4648-A440-B5D4162BD286Q39423649-A1CE994B-92C3-42A9-9A85-D77C20874B0BQ39440496-190126A1-A41F-47CF-8450-5E53425DABDDQ51468178-435B3AE0-F0B5-418F-B8E7-BA6094AFD6EDQ57897309-51C9B8FD-39C0-411E-AFBA-516A0A1A30AD
P2860
Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy--tolerance and addiction.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Clinical realities and economi ...... rapy--tolerance and addiction.
@en
type
label
Clinical realities and economi ...... rapy--tolerance and addiction.
@en
prefLabel
Clinical realities and economi ...... rapy--tolerance and addiction.
@en
P1476
Clinical realities and economi ...... rapy--tolerance and addiction.
@en
P2093
Portenoy RK
P304
P356
10.1016/S0885-3924(97)00168-1
P433
P577
1997-09-01T00:00:00Z